SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), which is focused on the development of DNA vaccines and its novel therapy for tumor ablation, announced today that the Company’s CEO, Avtar Dhillon, MD, will present a corporate overview on Inovio at the BIO CEO & Investor Conference 2007, Wednesday, February 14th, at 2:15 p.m. EST (11:15 a.m. PST). The conference will be held at the Waldorf=Astoria, New York City, February 12-14, 2007.
